Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 1
1994 2
1996 4
1997 1
1998 3
2000 3
2001 5
2002 1
2003 4
2004 1
2005 6
2006 5
2007 6
2008 1
2009 3
2010 2
2011 3
2012 2
2013 4
2014 3
2015 3
2016 3
2017 2
2018 2
2019 4
2020 4
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Results by year
Filters applied: . Clear all
Page 1
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy.
Woan KV, Kim H, Bjordahl R, Davis ZB, Gaidarova S, Goulding J, Hancock B, Mahmood S, Abujarour R, Wang H, Tuininga K, Zhang B, Wu CY, Kodal B, Khaw M, Bendzick L, Rogers P, Ge MQ, Bonello G, Meza M, Felices M, Huffman J, Dailey T, Lee TT, Walcheck B, Malmberg KJ, Blazar BR, Bryceson YT, Valamehr B, Miller JS, Cichocki F. Woan KV, et al. Among authors: walcheck b. Cell Stem Cell. 2021 Dec 2;28(12):2062-2075.e5. doi: 10.1016/j.stem.2021.08.013. Epub 2021 Sep 14. Cell Stem Cell. 2021. PMID: 34525347
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.
Pomeroy EJ, Hunzeker JT, Kluesner MG, Lahr WS, Smeester BA, Crosby MR, Lonetree CL, Yamamoto K, Bendzick L, Miller JS, Geller MA, Walcheck B, Felices M, Webber BR, Starr TK, Moriarity BS. Pomeroy EJ, et al. Among authors: walcheck b. Mol Ther. 2020 Jan 8;28(1):52-63. doi: 10.1016/j.ymthe.2019.10.009. Epub 2019 Oct 15. Mol Ther. 2020. PMID: 31704085 Free PMC article.
iNK-CD64/16A cells: a promising approach for ADCC?
Walcheck B, Wu J. Walcheck B, et al. Expert Opin Biol Ther. 2019 Dec;19(12):1229-1232. doi: 10.1080/14712598.2019.1667974. Epub 2019 Sep 19. Expert Opin Biol Ther. 2019. PMID: 31510805 Free PMC article.
Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation.
Mishra HK, Dixon KJ, Pore N, Felices M, Miller JS, Walcheck B. Mishra HK, et al. Among authors: walcheck b. Front Immunol. 2021 Jul 22;12:711621. doi: 10.3389/fimmu.2021.711621. eCollection 2021. Front Immunol. 2021. PMID: 34367174 Free PMC article.
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor.
Toffoli EC, Sheikhi A, Lameris R, King LA, van Vliet A, Walcheck B, Verheul HMW, Spanholtz J, Tuynman J, de Gruijl TD, van der Vliet HJ. Toffoli EC, et al. Among authors: walcheck b. Cancers (Basel). 2021 Oct 29;13(21):5446. doi: 10.3390/cancers13215446. Cancers (Basel). 2021. PMID: 34771609 Free PMC article.
82 results